Biotechnology eBooks
The FierceBiotech eBook library contains in-depth analyses of issues and challenges facing life sciences. Our expert editors provide their opinions and interview other industry leaders to explore topics beyond the headlines. Each eBook is available in PDF format for easy viewing.
Biomarkers: Lab to Clinic
Don’t miss this in-depth look at biomarkers. What role do they play in clinical trials? How do they factor into the diagnosis of diseases such as Alzheimer’s? What role does the FDA play in creating guidelines for biomarkers? Get the answers to these questions and more when you download this free eBook!
Cloud Primer for Life Sciences Execs: A Fierce Special Report
Our newest report highlights the growth of cloud service IT applications while providing examples of cost savings and efficiency gains that suggest the cloud is gaining traction in the life sciences industry.
Capitalizing on the Outsourcing Option
Risk areas for many biotechs and pharmas in today's changing market include lack of expertise and infrastructure. This eBook addresses recalibration challenges and strategies to capitalize using the contract development and manufacturing (CDMO) option.
Between an Industry Rock & a Political Hard Place: The FDA's 510(k) Initiative
The FDA's Center for Devices and Radiological Health revision of the 510(k) premarket notification process for medical devices involves a long and complicated journey. In a new eBook from the editors of FierceMedicalDevices, you will find the tools to help you understand the context for these changes.
Biomarkers Light The Way to Medicine's Future
Explore a new generation of molecular imaging biomarkers for use in diagnostics, drug testing, and treatment -- developed by NuView Life Sciences. Download this new eBook now!
Social Media for Pharma Brand Managers
This original e-book eBook was created by the FiercePharma editorial team as a guide to prepare pharma brand managers for the next wave in pharma social media use—including a look at the important legal, regulatory and strategic problems they'll encounter.
